Nectar Lifesciences’ Unit VI gets CGMP certification from SMDC

The State Service of Ukraine on Medicines and Drugs Control (SMDC) has granted the Certification of Good Manufacturing Practices for Medicinal products for Unit VI of Nectar Lifesciences Limited, located in Tehsil Baddi, District Solan, Himachal Pradesh. This Certification is valid for till April 18, 2026.

SES ESG Research assigns ESG rating of 69.3 to Cipla

SES ESG Research Private Limited, a SEBI registered ESG Rating Provider (SES), has independently assigned the Environmental, Social, and Governance (ESG) Rating of 69.3 (Grade B) (Adjusted) from 70.2 (Grade B+) (Adjusted) to Cipla Limited. The marginal decline in the ratings is attributed to lower scores in the Social and Governance parameters.

Marksans Pharma gets USFDA nod for acid reflux drug

The USFDA has granted final approval to Marksans Pharma Inc., a wholly-owned subsidiary of Marksans Pharma Ltd. This approval is for its Abbreviated New Drug Application (ANDA) of Omeprazole Delayed-Release Tablets 20mg (OTC).

The approved product is the generic version of AstraZeneca’s Prilosec Delayed-Release Tablets 20mg. It is used to treat heartburn and other conditions caused by excess stomach acid. These include gastric and duodenal ulcers, erosive esophagitis, and gastroesophageal reflux disease (GERD).